House of Lords Business
Show full summary

Lord Framlingham to ask Her Majesty's Government what assessment they have made of (1) clinical trial data showing the effectiveness of Ivermectin to treat COVID-19, and (2) the urgency of approving new treatments for COVID-19; and when they expect the Medicines and Healthcare products Regulatory Agency to come to a decision on approving Ivermectin for use in the UK.  HL4081

Question HL4081: tabled on 16 November 2021 and due for answer by 30 November 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Framlingham to ask Her Majesty's Government what assessment they have made of (1) clinical trial data showing the effectiveness of Ivermectin to treat COVID-19, and (2) the urgency of approving new treatments for COVID-19; and when they expect the Medicines and Healthcare products Regulatory Agency to come to a decision on approving Ivermectin for use in the UK.  HL4081
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Framlingham
Conservative
Life peer